| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-12 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |